<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32367696</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>May</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>Evolution of white matter damage in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>722</StartPage><EndPage>732</EndPage><MedlinePgn>722-732</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.51035</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To characterize disease evolution in amyotrophic lateral sclerosis using an event-based model designed to extract temporal information from cross-sectional data. Conventional methods for understanding mechanisms of rapidly progressive neurodegenerative disorders are limited by the subjectivity inherent in the selection of a limited range of measurements, and the need to acquire longitudinal data.</AbstractText><AbstractText Label="METHODS">The event-based model characterizes a disease as a series of events, each comprising a significant change in subject state. The model was applied to data from 154 patients and 128 healthy controls selected from five independent diffusion MRI datasets acquired in four different imaging laboratories between 1999 and 2016. The biomarkers modeled were mean fractional anisotropy values of white matter tracts implicated in amyotrophic lateral sclerosis. The cerebral portion of the corticospinal tract was divided into three segments.</AbstractText><AbstractText Label="RESULTS">Application of the model to the pooled datasets revealed that the corticospinal tracts were involved before other white matter tracts. Distal corticospinal tract segments were involved earlier than more proximal (i.e., cephalad) segments. In addition, the model revealed early ordering of fractional anisotropy change in the corpus callosum and subsequently in long association fibers.</AbstractText><AbstractText Label="INTERPRETATION">These findings represent data-driven evidence for early involvement of the corticospinal tracts and body of the corpus callosum in keeping with conventional approaches to image analysis, while providing new evidence to inform directional degeneration of the corticospinal tracts. This data-driven model provides new insight into the dynamics of neuronal damage in amyotrophic lateral sclerosis.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gabel</LastName><ForeName>Matt C</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0001-5373-011X</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Clinical Imaging Sciences Centre, Brighton and Sussex Medical School, University of Sussex, Brighton, East Sussex, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Broad</LastName><ForeName>Rebecca J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Trafford Centre, Brighton and Sussex Medical School, University of Sussex, Brighton, East Sussex, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Alexandra L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Centre for Medical Image Computing, Department of Computer Science, University College London, Gower Street, London, WC1E 6BT, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abrahams</LastName><ForeName>Sharon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychology, School of Philosophy, Psychology &amp; Language Sciences, Euan MacDonald Centre for Motor Neurone Disease Research, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bastin</LastName><ForeName>Mark E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Psychology, School of Philosophy, Psychology &amp; Language Sciences, Euan MacDonald Centre for Motor Neurone Disease Research, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menke</LastName><ForeName>Ricarda A L</ForeName><Initials>RAL</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Integrative Neuroimaging, FMRIB, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Chalabi</LastName><ForeName>Ammar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Basic and Clinical Neuroscience, King's College London, Maurice Wohl Clinical Neuroscience Institute, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, King's College Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldstein</LastName><ForeName>Laura H</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Department of Psychology, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsermentseli</LastName><ForeName>Stella</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3622-0171</Identifier><AffiliationInfo><Affiliation>Faculty of Education and Health, University of Greenwich, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexander</LastName><ForeName>Daniel C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Centre for Medical Image Computing, Department of Computer Science, University College London, Gower Street, London, WC1E 6BT, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Martin R</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0003-0267-3180</Identifier><AffiliationInfo><Affiliation>Wellcome Centre for Integrative Neuroimaging, FMRIB, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leigh</LastName><ForeName>P Nigel</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Trafford Centre, Brighton and Sussex Medical School, University of Sussex, Brighton, East Sussex, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cercignani</LastName><ForeName>Mara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Clinical Imaging Sciences Centre, Brighton and Sussex Medical School, University of Sussex, Brighton, East Sussex, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>GABEL/OCT16/966-799</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/K01014X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L501529/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>LEIGH/APR14/824-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>CERCIGNANI/OCT12/865-792</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>083477/Z/07/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0701923</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/R024804/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>TURNER/OCT18/989-797</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/T027800/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ann Clin Transl Neurol. 2020 Jul;7(7):1265</RefSource><PMID Version="1">32639090</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Ann Clin Transl Neurol. 2020 Jul;7(7):1266-1267</RefSource><PMID Version="1">32639092</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003337" MajorTopicYN="N">Corpus Callosum</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056324" MajorTopicYN="N">Diffusion Tensor Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008959" MajorTopicYN="N">Models, Neurological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011712" MajorTopicYN="N">Pyramidal Tracts</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066127" MajorTopicYN="N">White Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Gabel and Broad report grants from Motor Neurone Disease Association, during the conduct of the study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32367696</ArticleId><ArticleId IdType="pmc">PMC7261765</ArticleId><ArticleId IdType="doi">10.1002/acn3.51035</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Turner MR, Swash M. The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey. J Neurol Neurosurg Psychiatry 2015;86:667&#x2013;673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4453495</ArticleId><ArticleId IdType="pubmed">25644224</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche JC, Rojas&#x2010;Garcia R, Scott KM, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain 2012;135:847&#x2013;852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3286327</ArticleId><ArticleId IdType="pubmed">22271664</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Hammond ER, Mora G, et al. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2015;86:38&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">24336810</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Braak E. Neuropathological stageing of Alzheimer&#x2010;related changes. Acta Neuropathol 1991;82:239&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">1759558</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Brettschneider J, Ludolph AC, et al. Amyotrophic lateral sclerosis&#x2014;a model of corticofugal axonal spread. Nat Rev Neurol 2013;9:708&#x2013;714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J, M&#xfc;ller H&#x2010;P, Del Tredici K, et al. Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP&#x2010;43 pathology. Brain J Neurol 2014;137(Pt 6):1733&#x2013;1740.</Citation><ArticleIdList><ArticleId IdType="pubmed">24736303</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke RAL, Proudfoot M, Talbot K, Turner MR. The two&#x2010;year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis. NeuroImage Clin 2017;17:953&#x2013;961.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5752097</ArticleId><ArticleId IdType="pubmed">29321969</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J, M&#xfc;ller H&#x2010;P, Del Tredici K, et al. Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation&#x2010;based biological marker. J Neurol Neurosurg Psychiatry 2018;89:374&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5869447</ArticleId><ArticleId IdType="pubmed">29101254</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Benatar M. Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis. Muscle Nerve 2015;51:14&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4270289</ArticleId><ArticleId IdType="pubmed">25288265</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesalingam J, Stahl D, Wijesekera L, et al. Latent cluster analysis of ALS phenotypes identifies prognostically differing groups. PLoS ONE 2009;4:e7107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2741575</ArticleId><ArticleId IdType="pubmed">19771164</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonteijn HM, Modat M, Clarkson MJ, et al. An event&#x2010;based model for disease progression and its application in familial Alzheimer&#x2019;s disease and Huntington&#x2019;s disease. NeuroImage 2012;60:1880&#x2013;1889.</Citation><ArticleIdList><ArticleId IdType="pubmed">22281676</ArticleId></ArticleIdList></Reference><Reference><Citation>Young AL, Oxtoby NP, Daga P, et al. A data&#x2010;driven model of biomarker changes in sporadic Alzheimer&#x2019;s disease. Brain J Neurol 2014;137(Pt 9):2564&#x2013;2577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4132648</ArticleId><ArticleId IdType="pubmed">25012224</ArticleId></ArticleIdList></Reference><Reference><Citation>Young AL, Marinescu RV, Oxtoby NP, et al. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference. Nat Commun 2018;9:4273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6189176</ArticleId><ArticleId IdType="pubmed">30323170</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzi M, Filippone M, Frisoni GB, et al. Probabilistic disease progression modeling to characterize diagnostic uncertainty: application to staging and prediction in Alzheimer&#x2019;s disease. NeuroImage 2019;190:56&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">29079521</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxtoby NP, Young AL, Cash DM, et al. Data&#x2010;driven models of dominantly&#x2010;inherited Alzheimer&#x2019;s disease progression. Brain 2018;141:1529&#x2013;1544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5920320</ArticleId><ArticleId IdType="pubmed">29579160</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke RAL, Agosta F, Grosskreutz J, et al. Neuroimaging endpoints in amyotrophic lateral sclerosis. Neurotherapeutics 2017;14:11&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5233627</ArticleId><ArticleId IdType="pubmed">27752938</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones DK, Williams SCR, Gasston D, et al. Isotropic resolution diffusion tensor imaging with whole brain acquisition in a clinically acceptable time. Hum Brain Mapp 2002;15:216&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6871852</ArticleId><ArticleId IdType="pubmed">11835610</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Schneider T, Wheeler&#x2010;Kingshott CA, Alexander DC. NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. NeuroImage 2012;61:1000&#x2013;1016.</Citation><ArticleIdList><ArticleId IdType="pubmed">22484410</ArticleId></ArticleIdList></Reference><Reference><Citation>Broad RJ, Gabel MC, Dowell NG, et al. Neurite orientation and dispersion density imaging (NODDI) detects cortical and corticospinal tract degeneration in ALS. J Neurol Neurosurg Psychiatry 2019;90:404&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6581155</ArticleId><ArticleId IdType="pubmed">30361295</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Goldstein LH, Suckling J, et al. Frontotemporal white matter changes in amyotrophic lateral sclerosis. J Neurol 2005;252:321&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">15739047</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsermentseli S, Leigh PN, Taylor LJ, et al. Syntactic processing as a marker for cognitive impairment in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener 2015;17:69&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4732449</ArticleId><ArticleId IdType="pubmed">26312952</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettit LD, Bastin ME, Smith C, et al. Executive deficits, not processing speed relates to abnormalities in distinct prefrontal tracts in amyotrophic lateral sclerosis. Brain 2013;136:3290&#x2013;3304.</Citation><ArticleIdList><ArticleId IdType="pubmed">24056536</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori S, Wakana S, van Zijl PCM, Nagae&#x2010;Poetscher LM. MRI atlas of human white matter, 1st ed Amsterdam: Elsevier, 2005.</Citation></Reference><Reference><Citation>Fortin J&#x2010;P, Parker D, Tun&#xe7; B, et al. Harmonization of multi&#x2010;site diffusion tensor imaging data. NeuroImage 2017;161:149&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5736019</ArticleId><ArticleId IdType="pubmed">28826946</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis CM, Simmons A, Jones DK, et al. Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 1999;53:1051&#x2013;1058.</Citation><ArticleIdList><ArticleId IdType="pubmed">10496265</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H&#x2010;P, Turner MR, Grosskreutz J, et al. A large&#x2010;scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2016;87:570&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">26746186</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Pagani E, Rocca MA, et al. Voxel&#x2010;based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum Brain Mapp 2007;28:1430&#x2013;1438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6871473</ArticleId><ArticleId IdType="pubmed">17370339</ArticleId></ArticleIdList></Reference><Reference><Citation>Sage CA, Van Hecke W, Peeters R, et al. Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: revisited. Hum Brain Mapp 2009;30:3657&#x2013;3675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6870610</ArticleId><ArticleId IdType="pubmed">19404990</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciccarelli O, Behrens TE, Johansen&#x2010;Berg H, et al. Investigation of white matter pathology in ALS and PLS using tract&#x2010;based spatial statistics. Hum Brain Mapp 2009;30:615&#x2013;624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6870826</ArticleId><ArticleId IdType="pubmed">18172851</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini N, Douaud G, Mackay CE, et al. Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology 2010;75:1645&#x2013;1652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2974368</ArticleId><ArticleId IdType="pubmed">21041787</ArticleId></ArticleIdList></Reference><Reference><Citation>Sach M, Winkler G, Glauche V, et al. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain J Neurol 2004;127:340&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">14607785</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke RAL, K&#xf6;rner S, Filippini N, et al. Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis. Brain 2014;137:2546&#x2013;2555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4132644</ArticleId><ArticleId IdType="pubmed">24951638</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato K, Aoki S, Iwata NK, et al. Diffusion tensor tract&#x2010;specific analysis of the uncinate fasciculus in patients with amyotrophic lateral sclerosis. Neuroradiology 2010;52:729&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pubmed">20174788</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarro L, Agosta F, Canu E, et al. Cognitive functions and white matter tract damage in amyotrophic lateral sclerosis: a diffusion tensor tractography study. Am J Neuroradiol 2011;32:1866&#x2013;1872.</Citation><ArticleIdList><ArticleId IdType="pubmed">22016410</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois B, Hampel H, Feldman HH, et al. Preclinical Alzheimer&#x2019;s disease: definition, natural history, and diagnostic criteria. Alzheimers Dement J Alzheimers Assoc 2016;12:292&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417794</ArticleId><ArticleId IdType="pubmed">27012484</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxtoby NP, Garbarino S, Firth NC, et al. Data&#x2010;driven sequence of changes to anatomical brain connectivity in sporadic Alzheimer&#x2019;s disease. Front Neurol 2017;8:580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5681907</ArticleId><ArticleId IdType="pubmed">29163343</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierpaoli C, Basser PJ. Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med 1996;36:893&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pubmed">8946355</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavanagh JB. The problems of neurons with long axons. Lancet Lond Engl 1984;1:1284&#x2013;1287.</Citation><ArticleIdList><ArticleId IdType="pubmed">6144984</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownell B, Oppenheimer DR, Hughes JT. The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry 1970;33:338&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC493478</ArticleId><ArticleId IdType="pubmed">5431724</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A, Braak H, Del Tredici K, et al. Cortical influences drive amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2017;88:917&#x2013;924.</Citation><ArticleIdList><ArticleId IdType="pubmed">28710326</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Chen G, He M, et al. Altered white matter microarchitecture in amyotrophic lateral sclerosis: A voxel&#x2010;based meta&#x2010;analysis of diffusion tensor imaging. NeuroImage Clin 2018;19:122&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6051469</ArticleId><ArticleId IdType="pubmed">30035009</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsermentseli S, Leigh PN, Goldstein LH. The anatomy of cognitive impairment in amyotrophic lateral sclerosis: more than frontal lobe dysfunction. Cortex J Devoted Study Nerv Syst Behav 2012;48:166&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">21396632</ArticleId></ArticleIdList></Reference><Reference><Citation>Dick AS, Bernal B, Tremblay P. The language connectome: new pathways, new concepts. Neurosci Rev J Bringing Neurobiol Neurol. Psychiatry 2014;20:453&#x2013;467.</Citation></Reference><Reference><Citation>Herbet G, Zemmoura I, Duffau H. Functional anatomy of the inferior longitudinal fasciculus: from historical reports to current hypotheses. Front Neuroanat 2018;12:77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6156142</ArticleId><ArticleId IdType="pubmed">30283306</ArticleId></ArticleIdList></Reference><Reference><Citation>Briggs RG, Rahimi M, Conner AK, et al. A connectomic atlas of the human cerebrum&#x2010;chapter 15: tractographic description of the uncinate fasciculus. Oper Neurosurg 2018;15(suppl_1):S450&#x2013;S455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6890529</ArticleId><ArticleId IdType="pubmed">30260439</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorges M, Del Tredici K, Dreyhaupt J, et al. Corticoefferent pathology distribution in amyotrophic lateral sclerosis: in vivo evidence from a meta&#x2010;analysis of diffusion tensor imaging data. Sci Rep 2018;8:15389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6194130</ArticleId><ArticleId IdType="pubmed">30337677</ArticleId></ArticleIdList></Reference><Reference><Citation>Novikov DS, Kiselev VG, Jespersen SN. On modeling. Magn Reson Med 2018;79:3172&#x2013;3193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5905348</ArticleId><ArticleId IdType="pubmed">29493816</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster BR, Dwamena BA, Petrou M, et al. Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta&#x2010;analysis. Acad Radiol 2013;20:1099&#x2013;1106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4384461</ArticleId><ArticleId IdType="pubmed">23931423</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciccarelli O, Catani M, Johansen&#x2010;Berg H, et al. Diffusion&#x2010;based tractography in neurological disorders: concepts, applications, and future developments. Lancet Neurol 2008;7:715&#x2013;727.</Citation><ArticleIdList><ArticleId IdType="pubmed">18635020</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallebage&#x2010;Gamarallage M, Foxley S, Menke RAL, et al. Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: a post mortem whole brain sampling strategy for the integration of ultra&#x2010;high&#x2010;field MRI and quantitative neuropathology. BMC Neurosci 2018;19:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5848544</ArticleId><ArticleId IdType="pubmed">29529995</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>